HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gillette injunction against Norelco Reflex Action comparative ads partially granted.

This article was originally published in The Rose Sheet

Executive Summary

NORELCO REFLEX ACTION "LESS IRRITATION" SUPERIORITY CLAIMS CAN CONTINUE WITH DISCLAIMER, Boston federal court Judge Reginald Lindsay ruled Nov. 27 in response to Gillette's request for a preliminary injunction against the Philips Electronics division. The application for injunction was filed in conjunction with an Oct. 9 lawsuit, in which the wet shave manufacturer claimed that Norelco's "disparaging" Reflex Action electric shaver ads directly target Gillette's wet shave products ("The Rose Sheet" Oct. 21, p. 1). Pending a decision on the litigation, Gillette requested a preliminary injunction barring Norelco from running all TV, print and radio ads that feature disparaging comparison statements and negative images of wet shavers.

You may also be interested in...



Gillette's Norelco Survey Made "Significant Error" In Omitting Women - Judge

Gillette consumer perception studies submitted as evidence in the Gillette v. Norelco Reflex Action razor lawsuit were found to have a "significant error in methodology" because, in part, they failed to include women, Boston federal court Judge Reginald Lindsay ruled in his Oct. 6 decision against Gillette.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003529

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel